Supplementary
Macro, macroscopic characterization by the surgeon; Microscopic inspection, see Supplementary Table 3 for details; IC, immune cells; thinn., thinning; rupt., rupture; AR, autoradiography relative specific signal shown in Figure 5 ; ACE, ACI, ACC, arteria carotis externa, interna, communis; v, s, vulnerable, stable plaque; n, normal tissue; na, not available; m, male; f, female; TIA, transient ischemic attack; DM, diabetes mellitus; AH, arterial hypertension; HC, hypercholesterolemia; Sm, smoking; St, statins; BB, beta blocker; AC, anticoaculang; CA, calcium antagonist; ACEI, angiotensin converting enzyme inhibitor; ARA, angiotensin II receptor antagonist; PAI, platelet aggregation inhibitor; No sp. bi., no specific binding. Column-wise color coding, for patient numbers, increasing from white to grey; for scoring, age and AR, low (green), medium (yellow), high (red). Note, the investigated slice (microscopic inspection) may differ from the macroscopic gross characterization as tissues were in many cases heterogeneous. 

Supplementary Material and Methods
Conjugation, radiolabeling and quality control
Chemicals and solvents were purchased in trace analysis grade from Fluka or Sigma-Aldrich (Buchs, Switzerland) and were used without further purification. Briefly, conjugation of 92.3 µM belatacept was performed under metal-free conditions using a 20-fold molar excess of chelating agent. The reaction mixture was incubated overnight at 4°C yielding after purification in 1.4 mL protein conjugate solution with a concentration of 5.56 ± 0.02 mg/mL determined by a NanoDrop® ND-1000 spectrophotometer (Witec AG, Littau, Switzerland). Aliquots were stored at -20°C.
After radiolabeling (see main manuscript) the product (500 µL) was purified by FPLC on a Shimadzu SCL-10A VP system with a superose 12 column (GE Healthcare). Isocratic conditions with PBS (pH 7.4) as mobile phase and a flow rate of 0.5 mL/min were applied. Quality control of the purified product was performed under isocratic conditions (0.3 M NaCl, 0.05 M NaH 2 PO 4 , pH 6.2) with a TSKgel G3000SWxl column (7.8 mm x 30 cm, 5 µm; Tosoh Bioscience LLC). HPLC data were analyzed with the software RadioStar.
LC-MS analysis
LC-MS analysis was performed on a Waters LCT Premier mass spectrometer. Prior to analysis, conjugated belatacept was deglycosylated using a Protein Deglycosylation Mix (P6039, New England BioLabs Inc.). G7 reaction buffer (2.5 µL 10x concentrated) and 2.5 µL deglycosylation enzyme cocktail were added to 20 µL of 1.1 mg/mL belatacept in H 2 O and the mixture was incubated at 37°C overnight.
The deglycosylation mixture (20 µL) was mixed with 20 µL PBS (pH 7.4) and 2 µL 1 M DTT to reduce deglycosylated belatacept at 37°C for 30 min. Samples were chromatographed on an Aeris WIDEPORE XB-C18 column (3.6 µm, 100 mm x 2.1 mm; Phenomenex) heated to 80°C using the following gradient: 0 min to 3 min: 5% A, 90% B, 5% C; 3 min to 15 min: 5 to 75% A, 90 to 20% B, 5% C; 15 min to 20 min: 75 to 90% A, 20 to 5% B, 5% C (solvent A: acetonitrile + 0.1% formic acid, solvent B: water + 0.1% formic acid, solvent C: isopropanol) at a flow rate of 0.5 mL/min. The eluent was ionized using an electrospray source (ESI+). Data were collected with MassLynxV4.1 and deconvolution was performed using MaxEnt1. Payload ratios were calculated based on mass peak intensity.
Stability evaluation of 111
In-DOTA-belatacept
The in vitro stability of 111
In-DOTA-belatacept was evaluated in PBS (pH 7.4), human and murine (male NMRI nu/nu mice) blood plasma, respectively. Approximately 1.4 MBq radiotracer (20 µL, 76.5 nM) was added to 500 µL PBS or plasma and the samples were incubated at 37°C. Fifty-microliter samples were analyzed after 0, 24, 48 and 72 h by size-exclusion chromatography on a SCL-10A VP system (Shimadzu) equipped with a UV/Vis and a radiodetector. Chromatographic analysis corresponded with the conditions applied for quality control of the radiolabed product.
Cell culture
Raji cells were maintained in Roswell Park Memorial Institute (RPMI) 1640 medium with GlutaMAX (Gibco, Life Technologies) supplemented with 10% heat-inactivated fetal calf serum and penicillinstreptomycin. NCI-H69 cells were cultured in RPMI 1640 medium with GlutaMAX and 25 mM HEPES (Gibco, Life Technologies) supplemented with 10% heat-inactivated fetal calf serum, penicillinstreptomycin and 1 mM sodium pyruvate. Cells were cultured in suspension at 37°C in a humidified atmosphere containing 5% CO 2 . Routine culture treatment was performed twice a week.
Cell immunofluorescence microscopy
All incubation steps were performed at room temperature unless otherwise stated. Raji cells were seeded on 6-well tissue culture plates on the day of experiment and each well contained a disinfected coverslip. The cell culture medium was carefully removed and cells were fixed by incubation with 4% paraformaldehyde in PBS (pH 7.4) for 30 min. Thereafter, cells were permeabilized by incubation with methanol (10 min) and blocked with 2% bovine serum albumin (BSA) in TBS buffer (50 mM Tris, 150 mM NaCl, pH 7.4) for 30 min. The primary antibody was diluted to the appropriate concentration in 2% BSA/TBS and cells were incubated at 4°C overnight. The next day, cells were washed in TBS (3x, 10 min) and the secondary antibody was added in 2% BSA/TBS. The samples were incubated for 1 h and kept from that point on in dark. After washing in TBS (3x, 10 min), DAPI (1:5000) was added for 4 min to stain the nuclei of the cells. After three more washing steps with TBS (10 min each), the coverslips were mounted onto slides using ProLong® Gold antifade reagent (Life Technologies, Carlsbad, CA, USA) with cell-side facing down. For negative control, only secondary antibody was added to the cells. Slides were examined using an Axioskop 2 microscope equipped with 20/0.50 Plan-Neofluar, 40/1.3 oil PlanNeofluar, and 63/1.25 oil Plan-Neofluar objectives and an AxioCam digital camera (Carl Zeiss AG, Feldbach, Switzerland). Images were acquired using the AxioVision software (Carl Zeiss AG).
Tissue immunofluorescence microscopy
Raji or NCI-H69 xenografts were dissected from euthanized mice and embedded in Tissue-Tek (Thermo Scientific). Frozen sections (7 µm) were cut on a cryostat, thaw-mounted onto coated glass slides (Superfrost plus, Menzel) and stored at −20°C un l further use. Sections were fixed with ice cold methanol/aceton (1:1; v/v) for 5 min following a washing step with TBS for 5 min. The following blocking, incubation and washing procedures were performed under the same conditions as mentioned above for immunocytochemistry as well as the microscopic analysis.
